1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Presented in part at the American Society of Clinical Oncology Venous Thrombosis Guideline Committee Meeting, July 2006.
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment †
Impact on survival and bleeding complications
Article first published online: 17 JUL 2007
DOI: 10.1002/cncr.22892
Copyright © 2007 American Cancer Society
Additional Information
How to Cite
Kuderer, N. M., Khorana, A. A., Lyman, G. H. and Francis, C. W. (2007), A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment . Cancer, 110: 1149–1161. doi: 10.1002/cncr.22892
- †
Publication History
- Issue published online: 20 AUG 2007
- Article first published online: 17 JUL 2007
- Manuscript Accepted: 5 MAY 2007
- Manuscript Revised: 21 MAR 2007
- Manuscript Received: 25 JAN 2007
Funded by
- American Society of Clinical Oncology
- National Institutes of Health. Grant Number: T32HL07152-30
- National Cancer Institute. Grant Number: 1K23 CA120587-01A1
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , Heparosan-Derived Heparan Sulfate/Heparin-Like Compounds: One Kind of Potential Therapeutic Agents, Medicinal Research Reviews, 2012, 32, 3Direct Link:
- 2, , , , The thrombophilic state in cancer part II: Cancer outcomes, occult malignancy, and cancer suppression, Journal of Surgical Oncology, 2012, 105, 8Direct Link:
- 3, , , Treating venous thromboembolism in patients with cancer, Expert Review of Hematology, 2012, 5, 2, 201
- You have free access to this content4, , , Venous thromboembolism and cancer, ANZ Journal of Surgery, 2012, 82, 5Direct Link:
- 5, , Anticoagulant use in cancer patients, Expert Opinion on Pharmacotherapy, 2011, 12, 3, 351
- 6, , , , , , , How to improve the implementation of guidelines on cancer-related thrombosis, Expert Review of Anticancer Therapy, 2011, 11, 3, 473
- 7, , , , , , , LMWH Bemiparin and ULMWH RO-14 Reduce the Endothelial Angiogenic Features Elicited by Leukemia, Lung Cancer, or Breast Cancer Cells, Cancer Investigation, 2011, 29, 2, 153
- 8, , , Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines, Annals of Oncology, 2011, 22, Supplement 6, vi85
- You have free access to this content9, , Management of venous thromboembolism in patients with cancer, Journal of Thrombosis and Haemostasis, 2011, 9,Direct Link:
- 10, , , , , , Optimization of Small-Cell Lung Cancer Chemotherapy with Heparin: A Comprehensive Retrospective Study of 239 Patients Treated in a Single Specialized Center, Chemotherapy, 2011, 57, 3, 253
- 11, , , , , , , , , , , Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma, American Journal of Clinical Oncology, 2011, 34, 1, 70
- 12
- 13, , The impact of thromboprophylaxis on cancer survival: focus on pancreatic cancer, Expert Review of Anticancer Therapy, 2011, 11, 4, 579
- 14, , , , , , , Thermodynamic and biological evaluation of a thrombin binding aptamer modified with several unlocked nucleic acid (UNA) monomers and a 2′-C-piperazino-UNA monomer, Bioorganic & Medicinal Chemistry, 2011, 19, 16, 4739
- 15, Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants, Hematology, 2011, 2010, 1, 144
- 16, , Unlocked nucleic acid – an RNA modification with broad potential, Organic & Biomolecular Chemistry, 2011, 9, 10, 3591
- 17, Venous thromboembolism in the patient with cancer, Cancer, 2011, 117, 7Direct Link:
- 18, Antimetastatic activities of heparins and modified heparins. Experimental evidence, Thrombosis Research, 2010, 125, S66
- 19, , Cancer Patients and Awareness of Venous Thromboembolism, Cancer Investigation, 2010, 28, 1, 44
- 20, , , , Cancer prevention and vitamin K antagonists: An overview, Thrombosis Research, 2010, 125, S103
- 21, , , , , , , Lessons from French national guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients, Thrombosis Research, 2010, 125, S108
- 22, , , , Malignancy and hypercoagulability: a two-way association revisited, Journal of Thrombosis and Thrombolysis, 2010, 30, 3, 340
- 23, , Prevention and treatment of venous thromboembolism among patients with cancer: The American Society of Clinical Oncology Guidelines, Thrombosis Research, 2010, 125, S120
- 24
- 25, , , , The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy, Cancer, 2010, 116, 7Direct Link:
- 26, Thromboseprophylaxe und -therapie bei Tumorpatienten, best practice onkologie, 2010, 5, 1, 44
- 27, , , , Vena Cava Filters: Current Concepts and Controversies for the Surgeon, Current Problems in Surgery, 2010, 47, 7, 524
- 28, , , , Venous thromboembolism in malignant gliomas, Journal of Thrombosis and Haemostasis, 2010, 8, 2Direct Link:
- 29, , , , VTE prophylaxis for the medical patient: where do we stand? – A focus on cancer patients, Thrombosis Research, 2010, 125, S21
- 30
- 31, Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines, Cancer Treatment Reviews, 2009, 35, 8, 754
- 32, Cancer and thrombosis: implications of published guidelines for clinical practice, Annals of Oncology, 2009, 20, 10, 1619
- 33, , , , , , , Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients, Pathophysiology of Haemostasis and Thrombosis, 2009, 37, 2-4, 88
- 34, , International Recommendations for the Prevention and Treatment of Venous Thromboembolism Associated with Cancer, Clinical Drug Investigation, 2009, 29, 10, 625
- 35, , Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009, 29, 11Direct Link:
- 36, , , Procoagulant mechanisms in tumour cells, Best Practice & Research Clinical Haematology, 2009, 22, 1, 49
- 37, Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer, Cancer, 2009, 115, 24Direct Link:
- 38, Treatment of venous thromboembolism in cancer patients, Best Practice & Research Clinical Haematology, 2009, 22, 1, 93
- 39, , Coagulation, anticoagulation and pancreatic carcinoma, Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5, 8, 445
- 40, , Heparin as an anticancer therapeutic, Expert Opinion on Investigational Drugs, 2008, 17, 7, 1029
- 41, , , , , , , , , , , High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS), Blood, 2008, 112, 7, 2703
- 42
- 43, , , , , , , , , Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?, Supportive Care in Cancer, 2008, 16, 12, 1333
- 44, , Oncology,Direct Link:
- 45, , , , , , , , , , Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation, The Cochrane Library,Direct Link:
- 46, , , , , , , , , , Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation, The Cochrane Library,Direct Link: